JT001 (NLRP3-IN-19) is a potent, specific, and orally active NLRP3 inhibitor that impedes the assembly of the NLRP3 inflammasome, suppressing cytokine release and preventing pyroptosis. JT001 is utilized in research on nonalcoholic steatohepatitis and liver fibrosis [1].
Molecular Weight:
402.47
CAS Number:
[2238819-65-1]
Formula:
C19H22N4O4S
Target:
NOD-like Receptor (NLR)
T79695
* VAT and and shipping costs not included. Errors and price changes excepted
